IRIS
BRUNETTI, JLENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.793
EU - Europa 7.088
AS - Asia 3.112
SA - Sud America 489
Continente sconosciuto - Info sul continente non disponibili 284
AF - Africa 150
OC - Oceania 15
Totale 18.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.651
IT - Italia 1.883
GB - Regno Unito 1.386
RU - Federazione Russa 1.276
CN - Cina 1.015
SG - Singapore 914
IE - Irlanda 722
SE - Svezia 397
BR - Brasile 378
VN - Vietnam 347
DE - Germania 335
FR - Francia 280
UA - Ucraina 280
HK - Hong Kong 232
KR - Corea 167
FI - Finlandia 156
IN - India 121
ES - Italia 78
ZA - Sudafrica 78
CA - Canada 70
BD - Bangladesh 64
BE - Belgio 52
PL - Polonia 51
NL - Olanda 49
AR - Argentina 39
MX - Messico 38
JP - Giappone 33
PK - Pakistan 30
TR - Turchia 29
AT - Austria 28
CH - Svizzera 25
CZ - Repubblica Ceca 24
IR - Iran 22
IQ - Iraq 21
PH - Filippine 16
EC - Ecuador 15
CO - Colombia 14
NG - Nigeria 13
VE - Venezuela 13
AU - Australia 12
IL - Israele 12
KE - Kenya 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
LT - Lituania 10
RO - Romania 9
AZ - Azerbaigian 8
DZ - Algeria 8
EG - Egitto 8
ID - Indonesia 8
JM - Giamaica 8
PE - Perù 8
TN - Tunisia 8
UZ - Uzbekistan 8
BG - Bulgaria 7
KZ - Kazakistan 7
CI - Costa d'Avorio 6
CR - Costa Rica 6
EE - Estonia 6
PT - Portogallo 6
DK - Danimarca 5
JO - Giordania 5
SA - Arabia Saudita 5
AL - Albania 4
ET - Etiopia 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
UY - Uruguay 4
AM - Armenia 3
EU - Europa 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
PA - Panama 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
MM - Myanmar 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
SC - Seychelles 2
SI - Slovenia 2
TJ - Tagikistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 18.631
Salva come PNG Salva come JPEG
Città #
Southend 1.208
Dallas 834
Dublin 712
Ashburn 639
Fairfield 567
Singapore 530
San Jose 454
Chandler 402
Siena 398
Moscow 367
Milan 350
Santa Clara 315
Woodbridge 278
Ann Arbor 272
Beijing 272
Houston 235
Seattle 229
Council Bluffs 227
Jacksonville 227
Hong Kong 216
Wilmington 202
Hefei 200
Menlo Park 171
Seoul 163
Cambridge 160
Rome 151
New York 150
Los Angeles 138
Florence 116
Princeton 105
The Dalles 96
Ho Chi Minh City 92
Boardman 81
Munich 81
Johannesburg 74
Helsinki 72
Dong Ket 70
Nanjing 69
Lauterbourg 63
Hanoi 60
Columbus 58
Málaga 48
Shanghai 43
San Diego 41
Buffalo 39
London 39
Fremont 37
Orem 37
Brussels 36
Bengaluru 35
Dearborn 32
Phoenix 32
Nanchang 31
São Paulo 31
Atlanta 30
San Mateo 30
Warsaw 28
Chicago 27
Hebei 26
Brooklyn 25
Tokyo 25
Washington 25
Figino 24
Frankfurt am Main 23
Turku 23
Lappeenranta 22
Shenyang 22
Bagno a Ripoli 21
Naples 21
Chennai 20
Montreal 19
Tianjin 19
Vienna 19
Brno 18
Redondo Beach 18
Stockholm 18
Turin 18
Porto Alegre 17
Toronto 17
Düsseldorf 16
Paris 15
Redwood City 15
Gdansk 14
San Francisco 14
Abuja 13
Bologna 13
Da Nang 13
Dhaka 13
Kunming 13
Manchester 13
Mexico City 13
Nuremberg 13
Rio de Janeiro 13
Brasília 12
Denver 12
Poplar 12
Prato 12
Izmir 11
Amsterdam 10
Guangzhou 10
Totale 12.410
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 393
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 382
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 382
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 381
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 378
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 374
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 363
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 351
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 344
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 338
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 328
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 324
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 323
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 322
A new NT4 peptide-based drug delivery system for cancer treatment 322
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 318
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 316
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 313
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 312
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 308
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 306
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 299
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 293
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 291
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 291
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 284
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 283
Branched peptides as bioactive molecules for drug design 280
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 273
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 271
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 262
Nanoparticles exposing neurotensin tumor-specific drivers 253
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 251
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 250
Branched peptides as targeting agents for tumor imaging and therapy 250
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 250
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 250
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 244
Branched Neurotensin peptides for tumor personalized therapy 244
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 236
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 235
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 232
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 230
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 229
A selective Nile Red based solvatochromic probe: A study of fluorescence in LUVs and GUVs model membranes 228
The antimicrobial peptide M33. An example of drug development 224
Light-Switchable Membrane Permeability in Giant Unilamellar Vesicles 223
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 219
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 219
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 219
Tumor selective targeting by branched peptides 218
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases 217
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 216
The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly 216
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 214
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells 214
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 207
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 206
The Intraflagellar Transport Protein IFT20 Recruits ATG16L1 to Early Endosomes to Promote Autophagosome Formation in T Cells 203
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 195
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 194
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 186
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 180
The antimicrobial peptide M33. An example of drug development 175
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 172
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 171
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 170
null 165
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 159
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 157
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 108
null 105
A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis 96
Editorial: Proteoglycans in the Tumor Microenvironment 82
null 78
Novel role of Hippo effector YAP1 as a rheostat controlling inflammation in dendritic cells 44
Investigating the Cytoprotective Mechanisms of the Tardigrade Damage Suppressor (Dsup) Protein in Human Cells Under Hypoxic Stress 41
Photomodulation of vesicle dynamics using fluorescent photoswitchable amphiphiles 36
Immunomodulatory and Anti-inflammatory Activity in Vitro and in Vivo of a Novel Antimicrobial Candidate 15
Totale 18.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022988 0 0 65 100 99 61 57 66 57 145 129 209
2022/20231.493 76 155 180 194 170 248 45 133 111 66 68 47
2023/20241.317 39 33 108 84 75 366 414 35 10 33 30 90
2024/20252.511 77 100 309 125 305 145 116 183 195 92 268 596
2025/20266.431 436 745 718 767 1.201 211 671 181 276 396 215 614
2026/2027891 295 172 424 0 0 0 0 0 0 0 0 0
Totale 18.931